LSE:INDV

Indivior PLC Admission to the Official List and to Trading on the London Stock Exchange

SLOUGH, United Kingdom, Dec. 23, 2014 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior") will begin trading on the London Stock Exchange's main market at8 a.m. GMT today following the admission of 718,577,616 of its ordinary shares to the premium listing segment of the Official List of the...

2014-12-23 16:00 4379

Week's Top Stories

Most Reposted

Multiple achievements made in China-Hungary BRI conference

[Picked up by 319 media titles]

2024-05-03 06:59
Multiple achievements made in China-Hungary BRI conference

Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

[Picked up by 318 media titles]

2024-05-07 08:00
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity

VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

[Picked up by 316 media titles]

2024-05-08 14:37
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation

OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology

[Picked up by 309 media titles]

2024-05-08 08:00

IN2MF in Kuala Lumpur Presented by Bank Indonesia

[Picked up by 295 media titles]

2024-05-08 16:44
IN2MF in Kuala Lumpur Presented by Bank Indonesia

Most Read

/C O R R E C T I O N -- Addverb/

2024-05-03 20:26 15023
/C O R R E C T I O N -- Addverb/

Multiple achievements made in China-Hungary BRI conference

2024-05-03 06:59 10440
Multiple achievements made in China-Hungary BRI conference

Xinhua president, Hungarian economy minister vow to bolster media cooperation

2024-05-03 06:25 9815

Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

2024-05-03 14:47 6631
Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of Patients with Recurrent or Metastatic Solid Tumors in Late-breaking Oral Presentation at the 2024 ASCO Annual Meeting

2024-05-08 18:18 4994